Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden
· Delayed Price · Currency is SEK 16.50
-0.08 (-0.48%)
At close: Dec 3, 2025
Cinclus Pharma Holding AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 48.42 | 4.58 | 5.96 | 10.57 | - | - | Upgrade
|
| Revenue Growth (YoY) | - | -23.14% | -43.63% | - | - | - | Upgrade
|
| Gross Profit | 48.42 | 4.58 | 5.96 | 10.57 | - | - | Upgrade
|
| Selling, General & Admin | 49.55 | 36.85 | 39.56 | 64.12 | 14.45 | 2.61 | Upgrade
|
| Research & Development | 191.18 | 136.66 | 166.68 | 157.18 | 69.82 | 36.69 | Upgrade
|
| Operating Expenses | 242.15 | 173.51 | 206.24 | 221.3 | 84.27 | 39.29 | Upgrade
|
| Operating Income | -193.73 | -168.93 | -200.28 | -210.73 | -84.27 | -39.29 | Upgrade
|
| Interest Expense | -8.29 | -8.73 | -7.45 | -0.08 | -0.01 | - | Upgrade
|
| Interest & Investment Income | 26.19 | 11.21 | 3.03 | 1.18 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -2.08 | -2.08 | -10.49 | -21.39 | 8.01 | -3.65 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.24 | 1.24 | 0.58 | 0 | 0 | 0 | Upgrade
|
| Pretax Income | -176.67 | -167.28 | -214.61 | -231.01 | -76.27 | -42.94 | Upgrade
|
| Income Tax Expense | 0.38 | 0.75 | 0.51 | 18.06 | - | - | Upgrade
|
| Net Income | -177.05 | -168.03 | -215.12 | -249.07 | -76.27 | -42.94 | Upgrade
|
| Net Income to Common | -177.05 | -168.03 | -215.12 | -249.07 | -76.27 | -42.94 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 37 | 26 | 23 | 21 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 37 | 26 | 23 | 21 | 0 | Upgrade
|
| Shares Change (YoY) | 45.70% | 41.26% | 13.81% | 9.26% | 8415.70% | - | Upgrade
|
| EPS (Basic) | -3.80 | -4.54 | -8.20 | -10.81 | -3.62 | -173.37 | Upgrade
|
| EPS (Diluted) | -3.81 | -4.54 | -8.20 | -10.81 | -3.62 | -173.37 | Upgrade
|
| Free Cash Flow | -103.58 | -178.37 | -209.19 | -192.08 | -75.48 | -39.47 | Upgrade
|
| Free Cash Flow Per Share | -2.23 | -4.81 | -7.98 | -8.34 | -3.58 | -159.37 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | - | Upgrade
|
| Operating Margin | -400.11% | -3688.45% | -3360.98% | -1993.45% | - | - | Upgrade
|
| Profit Margin | -365.66% | -3668.80% | -3609.97% | -2356.20% | - | - | Upgrade
|
| Free Cash Flow Margin | -213.93% | -3894.48% | -3510.42% | -1817.01% | - | - | Upgrade
|
| EBITDA | -193.19 | -168.9 | -200.25 | -210.69 | -84.26 | -39.28 | Upgrade
|
| D&A For EBITDA | 0.54 | 0.03 | 0.03 | 0.04 | 0.01 | 0.01 | Upgrade
|
| EBIT | -193.73 | -168.93 | -200.28 | -210.73 | -84.27 | -39.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.